or Try an Advanced Search...

    ETF Components for GSEU - Goldman Sachs ActiveBeta Europe Equity ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVS B 0.18 1.64
    UL D 5.47 0.68
    STLA C -1.59 0.61
    DEO F -1.92 0.52
    E A -0.09 0.47
    ABBV C -0.91 0.43
    LOGI F -0.87 0.33
    BCS A 7.76 0.32
    CCEP B 1.00 0.19
    QGEN D -2.02 0.13
    LYG A 0.20 0.10
    AER A -0.40 0.09
    FLUT C -0.19 0.04

    Represented by ETF Holdings

    Keywords: Alcohol Asset Management Banking Biotechnology Cash Management Services Drink Eye Care Products General Insurance Insurance Products Molecular Diagnostics Pharmaceutical Acid Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Alcoholic Drinks Anemia Animal Health Antibiotics Asset Finance
    Industries: Drug Manufacturers - Major Airports & Air Services Auto Manufacturers Banks - Global Banks - Regional - Europe Beverages - Soft Drinks Beverages - Wineries & Distilleries Computer Systems Diagnostics & Research Gambling Household & Personal Products Oil & Gas Integrated

    Recent News for Goldman Sachs ActiveBeta Europe Equity ETF & its Holdings

    Date Stock Title
    Apr 25 UL 12 Countries with the Largest Slum Population in Europe
    Apr 25 UL Ben & Jerry’s social justice activism ‘a strength not a weakness’, insists Unilever
    Apr 25 BCS Top 3 Financial Stocks That Could Sink Your Portfolio This Quarter
    Apr 25 STLA Ram Announces New Off-road Truck Lineup With Benchmark Light- and Heavy-duty Offerings
    Apr 25 STLA All-new 2025 Ram 1500 RHO Offers Best Value, Fortifies Industry's Leading Light-duty Lineup
    Apr 25 ABBV UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
    Apr 25 UL Unilever expects “improvement” in nutrition volumes from Q2
    Apr 25 ABBV New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
    Apr 25 UL Investors Cheer Sales Growth at Ben & Jerry’s Owner Unilever
    Apr 25 STLA Law to limit petrol car sales is ‘terrible for the UK’, warns Vauxhall maker
    Apr 25 STLA To Lower Or Not? EV Pricing Dilemma Hampers Ford's Profitability, Warns Analyst
    Apr 25 UL Q1 2024 Sales/ Trading Statement Call
    Apr 25 UL Unilever Boosted by Power Brands as Consumers Trade Back Up
    Apr 25 UL Tatcha, Hourglass, Living Proof Power Unilever’s Growth in First Quarter
    Apr 24 ABBV AbbVie breaks six day winning cycle, trades in the red
    Apr 24 QGEN QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
    Apr 24 ABBV Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
    Apr 24 NVS Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
    Apr 24 ABBV 4 Large Drug Stocks to Hold on to Amid Industry Challenges
    Apr 24 AER AerCap (AER) Earnings Expected to Grow: Should You Buy?
    The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Goldman Sachs ActiveBeta® Europe Equity Index (the "index"). The fund seeks to achieve its investment objective by investing at least 80% of its assets (exclusive of collateral held from securities lending) in securities included in its underlying index, in depositary receipts representing securities included in its underlying index and in underlying stocks in respect of depositary receipts included in its underlying index. The index is designed to deliver exposure to equity securities of developed markets issuers in Europe.
    Exchange Traded Fund ETF Stock Market Index Collateralized Debt Obligation Goldman Sachs
    Back to the Main GSEU Page...